Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosis.

Fewings N, Gatt PN, McKay FC, Parnell GP, Schibeci SD, Edwards J, Basuki MA, Goldinger A, Fabis-Pedrini MJ, Kermode AG, Manrique CP, McCauley JL, Nickles D, Baranzini SE, Burke T, Vucic S, Stewart GJ, Booth DR.

Data Brief. 2017 Feb 21;11:364-370. doi: 10.1016/j.dib.2017.02.040. eCollection 2017 Apr.

2.

The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis.

Fewings NL, Gatt PN, McKay FC, Parnell GP, Schibeci SD, Edwards J, Basuki MA, Goldinger A, Fabis-Pedrini MJ, Kermode AG, Manrique CP, McCauley JL, Nickles D, Baranzini SE, Burke T, Vucic S, Stewart GJ, Booth DR.

J Autoimmun. 2017 Mar;78:57-69. doi: 10.1016/j.jaut.2016.12.006. Epub 2017 Jan 4.

PMID:
28063629
3.

Topical treatment with a two-component gel releasing nitric oxide cures C57BL/6 mice from cutaneous leishmaniasis caused by Leishmania major.

Butsch F, Lorenz B, Goldinger A, von Stebut E.

Exp Dermatol. 2016 Nov;25(11):914-916. doi: 10.1111/exd.13098. No abstract available.

PMID:
27249422
4.

The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies.

McKay FC, Gatt PN, Fewings N, Parnell GP, Schibeci SD, Basuki MA, Powell JE, Goldinger A, Fabis-Pedrini MJ, Kermode AG, Burke T, Vucic S, Stewart GJ, Booth DR.

Clin Immunol. 2016 Feb;163:96-107. doi: 10.1016/j.clim.2015.12.015. Epub 2016 Jan 4.

PMID:
26762769
5.

Seasonal effects on gene expression.

Goldinger A, Shakhbazov K, Henders AK, McRae AF, Montgomery GW, Powell JE.

PLoS One. 2015 May 29;10(5):e0126995. doi: 10.1371/journal.pone.0126995. eCollection 2015.

6.

Genetic and nongenetic variation revealed for the principal components of human gene expression.

Goldinger A, Henders AK, McRae AF, Martin NG, Gibson G, Montgomery GW, Visscher PM, Powell JE.

Genetics. 2013 Nov;195(3):1117-28. doi: 10.1534/genetics.113.153221. Epub 2013 Sep 11.

7.

A core metabolic enzyme mediates resistance to phosphine gas.

Schlipalius DI, Valmas N, Tuck AG, Jagadeesan R, Ma L, Kaur R, Goldinger A, Anderson C, Kuang J, Zuryn S, Mau YS, Cheng Q, Collins PJ, Nayak MK, Schirra HJ, Hilliard MA, Ebert PR.

Science. 2012 Nov 9;338(6108):807-10. doi: 10.1126/science.1224951.

PMID:
23139334
8.

A unique chromosomal rearrangement in the Cryptococcus neoformans var. grubii type strain enhances key phenotypes associated with virulence.

Morrow CA, Lee IR, Chow EW, Ormerod KL, Goldinger A, Byrnes EJ 3rd, Nielsen K, Heitman J, Schirra HJ, Fraser JA.

MBio. 2012 Feb 28;3(2). pii: e00310-11. doi: 10.1128/mBio.00310-11. Print 2012.

9.

["I have questions for the pharmacist!" Pharmaceutical care for the patient with osteoporosis].

Goldinger A.

Pharm Unserer Zeit. 2001;30(6):529-34. Review. German. No abstract available.

PMID:
11715686
10.

[Strychnine. An obsolete drug, but an important experimental tool in neurophysiology and -pharmacology].

Goldinger A, Müller WE.

Med Monatsschr Pharm. 1983 May;6(5):141-6. German. No abstract available.

PMID:
6855694
11.

Inhibition of glycine and GABA receptor binding by several opiate agonists and antagonists.

Goldinger A, Müller WE, Wollert U.

Gen Pharmacol. 1981;12(6):477-9. No abstract available.

PMID:
6273257
12.

Supplemental Content

Loading ...
Support Center